SB-200646A结构式
|
常用名 | SB-200646A | 英文名 | SB-200646A |
|---|---|---|---|---|
| CAS号 | 143797-62-0 | 分子量 | 302.759 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C15H15ClN4O | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
SB-200646A用途SB-200646A 是第一个对 5-HT2B/2C 的选择性超过 5-HT2A 的拮抗剂,5-HT2B,5-HT2C 和 5-HT2A 的 pKi 值分别为 7.5、6.9 和 5.2。SB-200646A 具有口服活性,在体内具有电生理和抗焦虑特性。 |
| 中文名 | SB 200646盐酸盐 |
|---|---|
| 英文名 | N-(1-Methyl-1H-5-indolyl)-N'-(3-pyridinyl)urea hydrochloride |
| 英文别名 | 更多 |
| 描述 | SB-200646A 是第一个对 5-HT2B/2C 的选择性超过 5-HT2A 的拮抗剂,5-HT2B,5-HT2C 和 5-HT2A 的 pKi 值分别为 7.5、6.9 和 5.2。SB-200646A 具有口服活性,在体内具有电生理和抗焦虑特性。 |
|---|---|
| 相关类别 | |
| 靶点实验 |
5-HT2B Receptor:7.5 (pKi) 5-HT2C Receptor:6.9 (pKi) 5-HT2A Receptor:5.2 (pKi) |
| 体外研究 | SB200646A(4μM)消除了乙醇引起的微小抑制性突触后电流(mIPSC)频率的增加,对基础mIPSC频率没有影响[1]。 |
| 体内研究 | SB-200646A(20 mg/kg;静脉注射;每天;持续21天;雄性白化Sprague-Dawley大鼠)治疗可显著减少自发性活动腹侧被盖区(VTA)多巴胺能神经元的数量[1]。静脉注射4-16 mg/kg的SB-200646A可显著提高自发活动的VTA多巴胺能神经元的放电率和爆发事件百分比,并显著增加黑质致密部(SNC)多巴胺能神经元的爆发事件百分比[1]。动物模型:雄性白化Sprague-Dawley大鼠(治疗开始时200-225g,实验时300-350g)[1]剂量:20mg/kg给药:静脉注射;每日;持续21天。结果:腹侧被盖区(VTA)多巴胺能神经元的数量显著减少。 |
| 参考文献 |
| 分子式 | C15H15ClN4O |
|---|---|
| 分子量 | 302.759 |
| 精确质量 | 302.093445 |
| InChIKey | IGRYPUQJEDJLHC-UHFFFAOYSA-N |
| SMILES | Cl.Cn1ccc2cc(NC(=O)Nc3cccnc3)ccc21 |
| 储存条件 | 2-8°C |
|
实验名称:Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay
来源:ChEMBL
靶标:N/A
External Id:CHEMBL1266185
|
|
实验名称:Antagonistic binding affinity measured against 5-hydroxytryptamine 2A receptor (human...
来源:ChEMBL
靶标:N/A
External Id:CHEMBL852624
|
|
实验名称:Cell-based high throughput primary assay to identify activators of GPR151
来源:The Scripps Research Institute Molecular Screening Center
靶标:RecName: Full=G-protein coupled receptor 151; AltName: Full=G-protein coupled receptor PGR7; AltName: Full=GPCR-2037; AltName: Full=Galanin receptor 4; AltName: Full=Galanin-receptor-like protein; Short=GalRL
External Id:GPR151_PHUNTER_AG_LUMI_1536_1X%ACT
|
|
实验名称:Tocris HTS for Inhibitors of Aerobactin Synthetase lucA
来源:23265
External Id:IucA Pilot Assay Tocris Library
|
|
实验名称:LOPAC HTS for Inhibitors of Aerobactin Synthetase IucA
来源:23265
靶标:IucA from hypervirulent Klebsiella pneumoniae
External Id:IucA Pilot Assay LOPAC Library
|
|
实验名称:Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green ...
来源:ChEMBL
靶标:Plasmodium falciparum
External Id:CHEMBL1267249
|
|
实验名称:Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green a...
来源:ChEMBL
靶标:Plasmodium falciparum
External Id:CHEMBL1267251
|
|
实验名称:HTS to identify compounds that affect the blood-brain barrier permeability in vitro
来源:26908
靶标:N/A
External Id:HTS97080
|
|
实验名称:In vivo potency to block hypolocomotion response to m-CPP in rat after oral administr...
来源:ChEMBL
靶标:Rattus norvegicus
External Id:CHEMBL788095
|
|
实验名称:AlphaScreen-based biochemical high throughput primary assay to identify activators of...
来源:The Scripps Research Institute Molecular Screening Center
靶标:N/A
External Id:FBW7_ACT_ALPHA_1536_1X%ACT PRUN
|
| 1-(1-Methyl-1H-indol-5-yl)-3-(3-pyridinyl)urea hydrochloride (1:1) |
| Urea, N-(1-methyl-1H-indol-5-yl)-N'-3-pyridinyl-, hydrochloride (1:1) |
| 1-(1-Methyl-1H-indol-5-yl)-3-pyridin-3-ylurea hydrochloride (1:1) |
| N-(1-Methyl-1H-5-indolyl)-N'-(3-pyridinyl)urea hydrochloride |